Last reviewed · How we verify
Firategrast gastro-retentive solution — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Firategrast gastro-retentive solution (Firategrast gastro-retentive solution) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Firategrast gastro-retentive solution TARGET | Firategrast gastro-retentive solution | GlaxoSmithKline | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Firategrast gastro-retentive solution CI watch — RSS
- Firategrast gastro-retentive solution CI watch — Atom
- Firategrast gastro-retentive solution CI watch — JSON
- Firategrast gastro-retentive solution alone — RSS
Cite this brief
Drug Landscape (2026). Firategrast gastro-retentive solution — Competitive Intelligence Brief. https://druglandscape.com/ci/firategrast-gastro-retentive-solution. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing